Virtual Medicinal Product (VMP)
-
Everolimus 5mg tablets
Name Details
Current Name
Everolimus 5mg tablets
|
Start Date
22-09-2009
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01EG02
BNF |
Current BNF
08010500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010500
|
Start Date
11-05-2010
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41763711000001109 |
09-05-2023 |
|
441726005 |
22-10-2009 |
08-05-2023 |
16074211000001108 |
22-09-2009 |
21-10-2009 |
VMP Ingredients
VMP ingredients table
Everolimus |
Based on Ingredient Substance |
|
5 mg |
|
Name
Everolimus
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Parent Products
-
VTM
Everolimus
-
VMP
(Current) Everolimus 5mg tablets
Virtual Medicinal Product Pack (VMPP) Information